Valuation: Avantor, Inc.

Market Cap 901.59Cr 773.38Cr 722.16Cr 662.57Cr 1.25TCr 86TCr 1.27TCr 8.52TCr 3.34TCr 43TCr 3.39TCr 3.31TCr 1,42900Cr P/E 2026 *
39.9x
P/E 2027 * 28.6x
Enterprise Value 1.21TCr 1.04TCr 968.26Cr 888.36Cr 1.67TCr 1,15500Cr 1.7TCr 11TCr 4.47TCr 58TCr 4.54TCr 4.44TCr 1,91600Cr EV / Sales 2026 *
1.83x
EV / Sales 2027 * 1.7x
Free-Float
95.49%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap.
31/07/26 Tax

Chief Financial Officer

-1,385 0.0002%
24/07/26 Tax

Compliance Officer

-1,201 0.0002%
23/02/26 Tax

Compliance Officer

2,376 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+4.73%-3.20% - - 901.59Cr
+1.55%+3.17%-12.82%+10.17% 19TCr
+2.22%+3.71%+4.71%+15.34% 12TCr
+0.31%+0.93%+7.60%+75.21% 6.03TCr
-3.33%-3.18%+29.54%+64.34% 5.51TCr
+3.78%+2.19%-5.27%-31.94% 4.92TCr
+0.31%-1.01%+11.10%-14.14% 3.38TCr
-0.62%-4.48% - - 2.99TCr
+1.79%+0.14%+42.84%-10.16% 2.44TCr
-4.11%-4.02%-11.35%+19.85% 2.38TCr
Average +0.49%-0.83%+8.29%+16.09% 5.98TCr
Weighted average by Cap. +0.61%+0.41%+1.84%+17.96%

Financials

2026 *2027 *
Net sales 659.37Cr 565.61Cr 528.15Cr 484.56Cr 911.21Cr 63TCr 926.22Cr 6.23TCr 2.44TCr 32TCr 2.48TCr 2.42TCr 1,04500Cr 674.97Cr 578.99Cr 540.65Cr 496.03Cr 932.78Cr 65TCr 948.13Cr 6.38TCr 2.5TCr 32TCr 2.53TCr 2.48TCr 1,07000Cr
Net income 23Cr 19Cr 18Cr 17Cr 31Cr 2.15TCr 32Cr 212.79Cr 83Cr 1.08TCr 85Cr 83Cr 3.57TCr 31Cr 27Cr 25Cr 23Cr 43Cr 2.97TCr 44Cr 293.73Cr 115.02Cr 1.49TCr 116.69Cr 114.15Cr 4.93TCr
Net Debt 307.24Cr 263.55Cr 246.1Cr 225.79Cr 424.59Cr 29TCr 431.58Cr 2.9TCr 1.14TCr 15TCr 1.15TCr 1.13TCr 49TCr 244.13Cr 209.41Cr 195.54Cr 179.41Cr 337.37Cr 23TCr 342.93Cr 2.31TCr 903.52Cr 12TCr 916.66Cr 896.71Cr 39TCr
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
20/26/20 $13.96 +4.73% 64,21,193
18/26/18 $13.33 -1.26% 63,10,268
17/26/17 $13.50 -1.17% 45,37,083
14/26/14 $13.66 -1.37% 39,64,759
13/26/13 $13.85 -0.57% 59,35,599
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
13.33USD
Average target price
14.56USD
Spread / Average Target
+9.26%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock